COLUMBUS, Ohio, Nov. 8, 2019 /PRNewswire/ -- Big Lots announced today the conclusion of the company's eighth point-of-sale fundraising campaign that benefits Nationwide Children's Hospital. The "Give Big for Kids" campaign raised a total of $3.05 million in more than 1,400 stores that employ over 35,000 Big Lots associates. Over the pas

SEATTLE and LUND, Sweden, Nov. 8, 2019 /PRNewswire/ -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics and Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immuno

BRUSSELS, Nov. 8, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced important new rheumatology data being presented on CIMZIA® (certolizumab pegol) and investigational molecules bimekizumab and dapirolizumab pegol at the 2019 American College of Rheumatology and the Association of Rheumatology Professionals (ACR/ARP) Annual Me

SAN FRANCISCO, Nov. 8, 2019 /PRNewswire/ -- Lexent Bio, Inc., a precision oncology company developing novel liquid biopsy systems, today announced a non-exclusive partnership with Illumina, Inc. (NASDAQ: ILMN) to develop an in-vitro diagnostic (IVD) kit for Lexent's future portfolio of next-generation sequencing (NGS)-based cancer diagnostics.The IVD kit under dev

LAINATE, Italy, Nov. 8, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Applicatio

PHOENIX, Nov. 8, 2019 /PRNewswire/ -- Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannab

WESTFORD, Mass., Nov. 8, 2019 /PRNewswire/ -- National Pressure Ulcer Advisory Panel (NPUAP) is pleased to announce that it has changed its name to the National Pressure Injury Advisory Panel (NPIAP).  The new name reflects the future direction of the organization and a reaffirming of our commitment to adopt the internationally preferred term, pressure injury,

SIMI VALLEY, Calif., Nov. 8, 2019 /PRNewswire/ -- EazyHold is one of 6 in the running to receive the 2019 first-ever Amazons Woman-Owned Small Business of the Year Award.An A

LAUSANNE, Switzerland, Nov. 8, 2019 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today it has been

Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth MADISON, Wis., Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its